Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing

James McCormick, Darren R Flower, Stephen Strobel, Diana L. Wallace, Peter C.L. Beverley, Elma Z. Tchilian

Research output: Contribution to journalArticle

Abstract

Hemophagocytic lymphohistiocytosis (HLH) composes a group of rare heterogenous disorders characterized by uncontrolled accumulation and infiltration of activated T lymphocytes and macrophages. Cytotoxic T and natural killer cell activity is significantly reduced or absent in these patients. Mutations in the important mediator of lymphocyte cytotoxicity perforin were identified in a number of HLH individuals. Here we report a novel missense mutation thr435met in the conserved Ca2+ binding domain of perforin in a patient with HLH. Prediction of the 3-dimensional structure of the thr435met perforin mutant using comparative molecular modeling indicates that the protein's ability to bind Ca2+, and therefore its cytolytic function, would be strongly compromised. In addition, this patient exhibited abnormal CD45 splicing caused by a C77G mutation in the gene encoding CD45 (PTPRC). Our findings suggest a combined role for perforin mutation and abnormal CD45 splicing as significant contributory factors in the pathogenesis of HLH.
Original languageEnglish
Pages (from-to)255-260
Number of pages6
JournalAmerican Journal of Medical Genetics Part A
Volume117A
Issue number3
DOIs
Publication statusPublished - Mar 2003

Fingerprint

Hemophagocytic Lymphohistiocytosis
Perforin
Mutation
Natural Killer T-Cells
Lymphokines
Missense Mutation
Macrophages
T-Lymphocytes
Genes
Proteins

Keywords

  • perforin
  • hlh
  • cd45 splicing
  • ptprc

Cite this

McCormick, J., Flower, D. R., Strobel, S., Wallace, D. L., Beverley, P. C. L., & Tchilian, E. Z. (2003). Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing. American Journal of Medical Genetics Part A , 117A(3), 255-260. https://doi.org/10.1002/ajmg.a.10010
McCormick, James ; Flower, Darren R ; Strobel, Stephen ; Wallace, Diana L. ; Beverley, Peter C.L. ; Tchilian, Elma Z. / Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing. In: American Journal of Medical Genetics Part A . 2003 ; Vol. 117A, No. 3. pp. 255-260.
@article{d1631532c3b14908ad08592c33e1a568,
title = "Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing",
abstract = "Hemophagocytic lymphohistiocytosis (HLH) composes a group of rare heterogenous disorders characterized by uncontrolled accumulation and infiltration of activated T lymphocytes and macrophages. Cytotoxic T and natural killer cell activity is significantly reduced or absent in these patients. Mutations in the important mediator of lymphocyte cytotoxicity perforin were identified in a number of HLH individuals. Here we report a novel missense mutation thr435met in the conserved Ca2+ binding domain of perforin in a patient with HLH. Prediction of the 3-dimensional structure of the thr435met perforin mutant using comparative molecular modeling indicates that the protein's ability to bind Ca2+, and therefore its cytolytic function, would be strongly compromised. In addition, this patient exhibited abnormal CD45 splicing caused by a C77G mutation in the gene encoding CD45 (PTPRC). Our findings suggest a combined role for perforin mutation and abnormal CD45 splicing as significant contributory factors in the pathogenesis of HLH.",
keywords = "perforin, hlh, cd45 splicing, ptprc",
author = "James McCormick and Flower, {Darren R} and Stephen Strobel and Wallace, {Diana L.} and Beverley, {Peter C.L.} and Tchilian, {Elma Z.}",
year = "2003",
month = "3",
doi = "10.1002/ajmg.a.10010",
language = "English",
volume = "117A",
pages = "255--260",
journal = "American Journal of Medical Genetics Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "3",

}

McCormick, J, Flower, DR, Strobel, S, Wallace, DL, Beverley, PCL & Tchilian, EZ 2003, 'Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing', American Journal of Medical Genetics Part A , vol. 117A, no. 3, pp. 255-260. https://doi.org/10.1002/ajmg.a.10010

Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing. / McCormick, James; Flower, Darren R; Strobel, Stephen; Wallace, Diana L.; Beverley, Peter C.L.; Tchilian, Elma Z.

In: American Journal of Medical Genetics Part A , Vol. 117A, No. 3, 03.2003, p. 255-260.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing

AU - McCormick, James

AU - Flower, Darren R

AU - Strobel, Stephen

AU - Wallace, Diana L.

AU - Beverley, Peter C.L.

AU - Tchilian, Elma Z.

PY - 2003/3

Y1 - 2003/3

N2 - Hemophagocytic lymphohistiocytosis (HLH) composes a group of rare heterogenous disorders characterized by uncontrolled accumulation and infiltration of activated T lymphocytes and macrophages. Cytotoxic T and natural killer cell activity is significantly reduced or absent in these patients. Mutations in the important mediator of lymphocyte cytotoxicity perforin were identified in a number of HLH individuals. Here we report a novel missense mutation thr435met in the conserved Ca2+ binding domain of perforin in a patient with HLH. Prediction of the 3-dimensional structure of the thr435met perforin mutant using comparative molecular modeling indicates that the protein's ability to bind Ca2+, and therefore its cytolytic function, would be strongly compromised. In addition, this patient exhibited abnormal CD45 splicing caused by a C77G mutation in the gene encoding CD45 (PTPRC). Our findings suggest a combined role for perforin mutation and abnormal CD45 splicing as significant contributory factors in the pathogenesis of HLH.

AB - Hemophagocytic lymphohistiocytosis (HLH) composes a group of rare heterogenous disorders characterized by uncontrolled accumulation and infiltration of activated T lymphocytes and macrophages. Cytotoxic T and natural killer cell activity is significantly reduced or absent in these patients. Mutations in the important mediator of lymphocyte cytotoxicity perforin were identified in a number of HLH individuals. Here we report a novel missense mutation thr435met in the conserved Ca2+ binding domain of perforin in a patient with HLH. Prediction of the 3-dimensional structure of the thr435met perforin mutant using comparative molecular modeling indicates that the protein's ability to bind Ca2+, and therefore its cytolytic function, would be strongly compromised. In addition, this patient exhibited abnormal CD45 splicing caused by a C77G mutation in the gene encoding CD45 (PTPRC). Our findings suggest a combined role for perforin mutation and abnormal CD45 splicing as significant contributory factors in the pathogenesis of HLH.

KW - perforin

KW - hlh

KW - cd45 splicing

KW - ptprc

UR - https://onlinelibrary.wiley.com/doi/full/10.1002/ajmg.a.10010

U2 - 10.1002/ajmg.a.10010

DO - 10.1002/ajmg.a.10010

M3 - Article

VL - 117A

SP - 255

EP - 260

JO - American Journal of Medical Genetics Part A

JF - American Journal of Medical Genetics Part A

SN - 1552-4825

IS - 3

ER -